Skip to main content
Caplight Logo









EvolVeritas Biotechnology Ltd.

EvolVeritas Biotechnology Ltd.

Private
BudapestHealthcare & Life Scienceshttps://evolveritas.com/

Last Round

Grant

Mar 22, 2022

Total Funding Raised

$943,700

Company Overview

EvolVeritas Biotechnology Ltd. is a biotechnology company that develops drug compounds through the development of specific protein molecules for therapeutic areas such as ischemic reperfusion injury, thrombosis, and COVID-19.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

directed protein evolutionphage display platformdrug candidate developmentstructure-driven protein engineeringischemia-reperfusion injuryMASP-2 inhibitorbiologics discoverytherapeutic proteinpreclinical biotechdrug licensingviral infection therapeuticsresearch tool ligandsbiotech spinoffrecombinant protein productionIgA nephropathy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EvolVeritas Biotechnology Ltd. Comparables

Compare EvolVeritas Biotechnology Ltd. with similar companies based on industry and business-model similarity.

EvolVeritas Biotechnology Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Transcenta Holding
76%
KeyMed Biosciences
73%
RevolKa Ltd.
72%

EvolVeritas Biotechnology Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 22, 2022

EvolVeritas Biotechnology Ltd. Investors

Notable investors and investment history

EvolVeritas Biotechnology Ltd. investors
InvestorRounds
PBG FMC Venture Capital Fund ManagementSeed
National Research, Development and Innovation OfficeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2022

    $922K grant from National Research, Development and Innovation Office.

EvolVeritas Biotechnology Ltd. Filings

Explore SEC and related filing metadata, where available.

EvolVeritas Biotechnology Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EvolVeritas Biotechnology Ltd.'s valuation, stock price, and market status.

Is EvolVeritas Biotechnology Ltd. a public or private company?

EvolVeritas Biotechnology Ltd. is a private company.

What is the current stock price of EvolVeritas Biotechnology Ltd.?

EvolVeritas Biotechnology Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is EvolVeritas Biotechnology Ltd. worth (valuation)?

Valuation information for EvolVeritas Biotechnology Ltd. is not publicly available.

Can I buy EvolVeritas Biotechnology Ltd. stock?

EvolVeritas Biotechnology Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EvolVeritas Biotechnology Ltd.'s last funding round?

EvolVeritas Biotechnology Ltd.'s most recent funding round was Grant on March 22, 2022.

Who are the main investors in EvolVeritas Biotechnology Ltd.?

Key investors in EvolVeritas Biotechnology Ltd. include PBG FMC Venture Capital Fund Management, National Research, Development and Innovation Office.

Will EvolVeritas Biotechnology Ltd. IPO soon?

No public IPO plans have been announced for EvolVeritas Biotechnology Ltd..

How can I track EvolVeritas Biotechnology Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EvolVeritas Biotechnology Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBudapest
Year Founded2011
Last FundingMar 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?